MedPath

A prospective study of the usefulness of liquid biopsy as biomarker during diagnosis and treatment for the endometrial cancer

Not Applicable
Recruiting
Conditions
endometrial cancer
Registration Number
JPRN-UMIN000027122
Lead Sponsor
Wakayama medical university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

The patients are followed our protocol.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concordance rate of liquid biopsy and gene mutation in tumor tissue specimen
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath